Teekay director sells 400 shares after exercise
A Teekay director exercised 400 options and sold 400 common shares in a same-day transaction.
Rhea-AI Filing Summary
TEEKAY CORP LTD (TK) director Heidi Simon Locke reported a same-day option exercise and share sale on September 17, 2026. She exercised 400 stock options for Common Stock at an exercise price of $5.81 per share, acquiring 400 shares, then sold 400 Common shares at a weighted average price of $14.93 per share. Following the transaction, she held 9,600 stock options directly, with an exercise price of $5.81 and an expiration date of June 7, 2033. No Rule 10b5-1 trading plan is reported.
Positive
- None.
Negative
- None.
Insider Trade Summary
Exercise and Sale: 400 shares ($4K approx. pre-tax spread)
Exercise and Sale
3 txns
Insider
Locke Simon Heidi
Role
Director
Sold
400 shs ($6K)
Approx. gross sale proceeds
$6K
Approx. exercise cost
$2K
Approx. pre-tax spread
$4K
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option ("Right to Buy") | 400 | $5.81 | $2K |
| Exercise | Common Stock | 400 | $5.81 | $2K |
| Sale | Common Stock F1 | 400 | $14.93 | $6K |
Holdings After Transaction:
Stock Option ("Right to Buy") — 9,600 contracts (Direct);
Common Stock — 46,000.5095 shares (Direct)
Footnotes (1)
- F1. The transaction was executed in multiple trades all of which were at $14.93. The price reported above reflects the weighted average sale price.
Key Figures
Options exercised: 400 shares
Exercise price: $5.81 per share
Shares sold: 400 shares
+3 more
6 metrics
Options exercised
400 shares
Stock options exercised into Common Stock on September 17, 2026
Exercise price
$5.81 per share
Exercise price of Stock Option ("Right to Buy")
Shares sold
400 shares
Common Stock sold on September 17, 2026
Weighted average sale price
$14.93 per share
Common Stock sale executed in multiple trades
Options held after transaction
9,600 options
Stock options directly owned following the option exercise
Option expiration date
June 7, 2033
Expiration of Stock Option ("Right to Buy")
Key Terms
Stock Option ("Right to Buy"), derivative security, weighted average sale price
3 terms
Stock Option ("Right to Buy") financial
"The security title is listed as Stock Option ("Right to Buy")."
derivative security financial
"Described as an exercise or conversion of derivative security."
A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.
weighted average sale price financial
"The price reported reflects the weighted average sale price."
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transactions did Teekay (TK) director Heidi Simon Locke report?
She reported exercising 400 stock options for Common Stock at $5.81 per share and selling 400 Common shares at a weighted average price of $14.93 per share on September 17, 2026.
How many Teekay (TK) stock options does the director hold after this Form 4?
After the reported transactions, the director held 9,600 stock options directly, each with an exercise price of $5.81 and an expiration date of June 7, 2033.
At what prices were the Teekay (TK) transactions executed on September 17, 2026?
The stock options were exercised at an exercise price of $5.81 per share, and the resulting 400 Common shares were sold at a weighted average sale price of $14.93 per share based on multiple trades.
Were the reported Teekay (TK) insider trades under a Rule 10b5-1 plan?
No. The filing indicates that no Rule 10b5-1 trading plan is affirmed for the reported transactions.
What type of derivative security did the Teekay (TK) director exercise?
The director exercised a Stock Option ("Right to Buy") derivative security for 400 underlying shares of Common Stock at an exercise price of $5.81 per share, originally exercisable from June 7, 2023 and expiring on June 7, 2033.
AI-generated analysis. How Rhea-AI works. Not financial advice.